Northwestern Medicine investigators have discovered how a particular type of immune cell exerts a dual function in cancer cells that is contingent on tumor grade.
Browsing: Melissa Rohman
More than 350 participants attended the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease’s virtual PPA Conference, which featured keynote speakers and group support sessions focused on Primary Progressive Aphasia.
Inhibiting a novel protein variant within glioma stem cells may be a promising therapeutic approach to treat glioblastoma, according to a recent Northwestern Medicine study.
It’s been one year since the first case of COVID-19 was detected in the United States, and still Feinberg investigators continue to investigate the disease, its evolution and its impact on society.
Northwestern Medicine investigators have discovered that inhibiting tumor-associated myeloid cells ability to produce specialized metabolites called polyamines may improve the effectiveness of treatments for glioblastoma.
Since March 2020, a team of Northwestern Medicine scientists have been tracking the evolution of SARS- CoV-2, specifically in the city of Chicago. Their work has been pivotal in understanding how the virus spread to Chicago and what new variants have emerged in the city.
Forty-four new members were inducted into Northwestern’s chapter of the Alpha Omega Alpha medical honor society during a virtual ceremony on March 17.
Feinberg’s Department of Pharmacology has expanded in size, faculty, and research focus, and is looking ahead to future growth in the field.
Linda Suleiman, MD, ’17 GME, and Quentin Youmans, ’15 MD, ’18 GME, have been included in the National Minority Quality Forum’s 2021 “40 Under 40 Leaders in Minority Health” list.
Endoscopic submucosal dissection can be performed as safely and effectively as alternative techniques and is associated with lower cancer recurrence, according to a recent study.